Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Device Week – March 14, 2016

This article was originally published in The Gray Sheet

Executive Summary

On this week's podcast, The Gray Sheet team discusses recent actions in the Senate HELP Committee, including committee passage of a breakthrough device bill. We also talk about the case of a novel fecal-incontinence device, which gained unanimous support from an FDA panel just days before the parent company announced plans to shut down the unit that makes the device, and we look at device cybersecurity in the Europe versus the US.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT034595

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel